Driving Innovation through Licensing Competitive Intelligence and Big Data…
11
Driving Innovation through Licensing, Competitive Intelligence and Big Data Analytics John D’Antonio, Director, Life Sciences Advisory Services, Licensing & Competitive Intelligence Rick Ruiz Director, Practice Leader Information Integration & Analytics 1
-
Upload
paragon-solutions -
Category
Technology
-
view
1.145 -
download
2
description
To see the demo, download it here: http://www.consultparagon.com/webinar-driving-innovation-through-licensing-competitive-intelligence-and-big-data-analytics.html Today’s pharmaceutical companies are in a competitive brawl to rapidly identify, value and license promising drug candidates from external sources. This requires a significant investment in time and money, with no guarantee of success. To identify product opportunities ahead of a competitor requires a unique blend of competitive intelligence, advanced search and qualification technology, and the ability to quickly and accurately value a potential investment. In this session, you will learn how to maximize the investment in time spent searching, qualifying and valuing new assets. This approach offers competitive advantage by putting key information used to decide whether to accelerate, abandon or hold on an opportunity at licensing and acquisitions executives’ fingertips.
Transcript of Driving Innovation through Licensing Competitive Intelligence and Big Data…
Driving Innovation through Licensing, Competitive Intelligence and Big Data Analytics
John D’Antonio, Director, Life Sciences Advisory Services, Licensing & Competitive Intelligence Rick Ruiz Director, Practice Leader Information Integration & Analytics
1
About Paragon
Deep Pharmaceutical and Life sciences industry expertise
Solution competencies for process optimization, channel
and supply chain, analytics, licensing, information
management
Advisory services consulting and execution delivering
practical business value
Industry-aligned accelerators provide rapid time-to-value
and lower total cost of ownership.
A proven delivery track record and return on investment
Leading mid-tier information solutions
company that helps firms leverage
assets to maximize business results.
Corporate Facts • National Coverage
• Global Clients
• NJ Headquarters
• Dual-shore Development
• CAGR 20+%
• Privately owned, 30-year history
Rapidly finding and screening assets
• Search highly manual, extremely time consuming
• No comprehensive overview to find useful
information
• Unapparent connections between topics hidden
Missed opportunities
• Drug companies late in the game, then overpay
• Differentiation and positioning weakened
• Competition gets in first
• Retrieving complex data from multiple disparate
locations a costly bottleneck
The Problem
4
The Opportunity
Significance
6
The Value
Opportunity Assessment Team
BD&L • Fit & Closure
• Timing
• Potential
Finance • Valuation
• Risk
• Operating
Income
CEO • EPS
• Pipeline
• Competitors
R&D • Pipeline
• Efficacy
• Utility
IP • Royalties
• Patent Validity
• Infringement
Clinical &
Regulatory • Pathway
• Development
Cost
• Approval
Manufacturing • Scalability
• Complexity
• Batch Cost
Partnerships
Para
gon
Orc
hestr
ate
d S
olu
tion
Analytic Technology
Semantic Intelligence Engine
Cortellis Industry Data
Financial Decision Analysis
Drug Chemistry
Demo
Questions???
Thank You
John D’Antonio, Director, Life Sciences Advisory Services,
Licensing & Competitive Intelligence
mobile: 609-577-0755
Rick Ruiz
Director, Practice Leader
Information Integration & Analytics
mobile: 732.535.1920
